This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matson, D O Articles by Estes, M K Search for Related Content PubMed PubMed Citation Articles by Matson, D O Articles by Estes, M K

Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays.

Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.

ABSTRACT

Knowledge of the immune response to rotavirus is crucial for vaccine development. We compared an epitope-blocking assay (EBA) that uses VP7-specific monoclonal antibodies with neutralization assays (NAs) with polyclonal antisera for detecting serum antibody responses after natural rotavirus infection in children. Twenty-six serum pairs from children living in an orphanage with and without symptoms during two rotavirus outbreaks were evaluated for VP7 type 1-, 2-, 3-, and 4-specific antibody responses. In the first outbreak, which was caused by a VP7 type 3 strain, homotypic antibody responses were detected in 11 of 11 symptomatic children by NA and in 10 of 11 symptomatic children by EBA. Heterotypic antibody responses were detected more frequently (12 of 15 children) by NA than by EBA, and the heterotypic epitope-blocking antibody responses occurred in children older than 14 months of age. Antibody responses in asymptomatic children were more commonly detected by EBA than by NA. EBA results from the sera of children in the second outbreak indicated that it was caused by VP7 type 4, whereas NA results suggested it was caused by VP7 type 3. Our results confirm that EBA is a sensitive and specific method for determining VP7 type-specific immune responses after natural rotavirus infections.

This article has been cited by other articles:

• Dennehy, P. H. (2008). Rotavirus Vaccines: an Overview. Clin. Microbiol. Rev. 21: 198-208 [Abstract] [Full Text]  
• Blutt, S. E., Crawford, S. E., Warfield, K. L., Lewis, D. E., Estes, M. K., Conner, M. E. (2004). The VP7 Outer Capsid Protein of Rotavirus Induces Polyclonal B-Cell Activation. J. Virol. 78: 6974-6981 [Abstract] [Full Text]  
• Menchaca, G., Padilla-Noriega, L., Méndez-Toss, M., Contreras, J. F., Puerto, F. I., Guiscafré, H., Mota, F., Herrera, I., Cedillo, R., Muñoz, O., Ward, R., Hoshino, Y., López, S., Arias, C. F. (1998). . CVI 5: 328-334 [Abstract] [Full Text]